Medivapom (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in neurons. This binding limits calcium entry during nerve activation, which in turn decreases the release of excitatory neurotransmitters like glutamate and substance P. The result is reduced neuronal hyper‑excitability, helping control seizures and alleviate neuropathic pain.

The appropriate dose of Medivapom is individualized by the prescribing clinician based on the patient’s condition, renal function, age and response to therapy. Dosage regimens can differ widely, so patients should follow the specific instructions provided by their healthcare professional.

Safety data for gabapentin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their prescriber.

To request Medivapom, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Gabapentin (Medivapom) is a first‑line oral agent for neuropathic pain and is often compared with pregabalin, another α2δ ligand. Both have similar mechanisms, but pregabalin generally has higher bioavailability and may require lower dosing. Choice between them depends on efficacy, tolerability, patient comorbidities and cost considerations.

Medivapom should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain stability.

Medivapom is taken orally, usually with or without food, as directed by the prescriber. Tablets (or the appropriate oral formulation) should be swallowed whole with a glass of water. The dosing schedule—once daily, twice daily, or more—depends on the individual treatment plan.

Serious adverse events, though uncommon, include severe allergic reactions (anaphylaxis, angioedema), Stevens‑Johnson syndrome, suicidal ideation, respiratory depression when combined with other CNS depressants, hepatic failure, and blood dyscrasias such as agranulocytosis. Patients should seek immediate medical attention if any of these occur.

Medivapom is contraindicated in patients with known hypersensitivity to gabapentin or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled depression, or a history of suicidal behavior. Pregnant or breastfeeding women should only use it after a thorough risk‑benefit assessment by their healthcare provider.